{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T23:06:36Z","timestamp":1790291196723,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T00:00:00Z","timestamp":1728432000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","redjournal.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.ijrobp.2024.09.051","type":"journal-article","created":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T02:45:04Z","timestamp":1727750704000},"page":"145-152","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Stereotactic Radiation Therapy in 3 Fractions for T1 Glottic Cancer"],"prefix":"10.1016","volume":"121","author":[{"given":"Giuseppe","family":"Sanguineti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasqualina","family":"D'Urso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Bottero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Farneti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Goanta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Giannarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Landoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2024.09.051_bib0001","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1002\/ijc.25516","article-title":"Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008","volume":"127","author":"Ferlay","year":"2010","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ijrobp.2024.09.051_bib0002","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ijrobp.2005.06.014","article-title":"Radiotherapy for early glottic carcinoma (T1N0M0): results of prospective randomized study of radiation fraction size and overall treatment time","volume":"64","author":"Yamazaki","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.09.051_bib0003","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.ijrobp.2009.08.066","article-title":"T1N0 to T2N0 squamous cell carcinoma of the glottic larynx treated with definitive radiotherapy","volume":"78","author":"Chera","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.09.051_bib0004","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.radonc.2013.09.016","article-title":"A prospective randomized trial comparing hypofractionation with conventional fractionation radiotherapy for T1-2 glottic squamous cell carcinomas: results of a Korean Radiation Oncology Group (KROG-0201) study","volume":"110","author":"Moon","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2024.09.051_bib0005","doi-asserted-by":"crossref","first-page":"5352","DOI":"10.3390\/jcm11185352","article-title":"Open partial laryngectomies: history of laryngeal cancer surgery","volume":"11","author":"Hans","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.ijrobp.2024.09.051_bib0006","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.3389\/fonc.2020.01447","article-title":"Is single cord irradiation going to be a new standard for T1a glottic carcinoma?","volume":"10","author":"Kocak Uzel","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.ijrobp.2024.09.051_bib0007","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.1007\/s00405-023-07904-2","article-title":"Oncological outcome of vocal cord-only radiotherapy for CT1-T2 glottic laryngeal squamous cell carcinoma","volume":"280","author":"de Ridder","year":"2023","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.ijrobp.2024.09.051_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2022.105782","article-title":"Single vocal cord irradiation for early-stage glottic cancer: excellent local control and favorable toxicity profile","volume":"127","author":"Tans","year":"2022","journal-title":"Oral Oncol"},{"key":"10.1016\/j.ijrobp.2024.09.051_bib0009","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1002\/hed.26052","article-title":"Feasibility of single vocal cord irradiation as a treatment strategy for T1a glottic cancer","volume":"42","author":"Chung","year":"2020","journal-title":"Head Neck"},{"key":"10.1016\/j.ijrobp.2024.09.051_bib0010","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.oraloncology.2015.02.003","article-title":"Carotid sparing intensity-modulated radiation therapy achieves comparable locoregional control to conventional radiotherapy in T1-2N0 laryngeal carcinoma","volume":"51","author":"Zumsteg","year":"2015","journal-title":"Oral Oncol"},{"key":"10.1016\/j.ijrobp.2024.09.051_bib0011","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/lary.27873","article-title":"Outcomes of carotid-sparing IMRT for T1 glottic cancer: comparison with conventional radiation","volume":"130","author":"Mohamed","year":"2020","journal-title":"Laryngoscope"},{"key":"10.1016\/j.ijrobp.2024.09.051_bib0012","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1002\/hed.27101","article-title":"Outcomes of carotid sparing intensity-modulated radiotherapy for early stage glottic cancer in 201 patients: multicenter study of Turkish Radiation Oncology Society\/TROD-01-007","volume":"44","author":"Bicakci","year":"2022","journal-title":"Head Neck"},{"key":"10.1016\/j.ijrobp.2024.09.051_bib0013","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ijrobp.2019.05.011","article-title":"SBRT for early stage larynx: a go or no go? It's all in the delivery","volume":"105","author":"Mueller","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.09.051_bib0014","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ijrobp.2019.09.042","article-title":"In regard to Sher et al","volume":"106","author":"Mendenhall","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"10.1016\/j.ijrobp.2024.09.051_bib0015","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ijrobp.2019.03.011","article-title":"Early closure of a phase 1 clinical trial for SABR in early-stage glottic cancer","volume":"105","author":"Kang","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.09.051_bib0016","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ijrobp.2019.03.010","article-title":"Phase 1 fractional dose-escalation study of equipotent stereotactic radiation therapy regimens for early-stage glottic larynx cancer","volume":"105","author":"Sher","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.09.051_bib0017","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1177\/03008916211000440","article-title":"Stereotactic body radiotherapy for t1 glottic cancer: Dosimetric data in 27 consecutive patients","volume":"107","author":"Sanguineti","year":"2021","journal-title":"Tumori"},{"key":"10.1016\/j.ijrobp.2024.09.051_bib0018","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s13014-021-01833-2","article-title":"Organ motion in linac-based sbrt for glottic cancer","volume":"16","author":"Perillo","year":"2021","journal-title":"Radiat oncol"},{"key":"10.1016\/j.ijrobp.2024.09.051_bib0019","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0172055","article-title":"SBRT for early-stage glottic larynx cancer-initial clinical outcomes from a phase I clinical trial","volume":"12","author":"Schwartz","year":"2017","journal-title":"PLOS ONE"},{"key":"10.1016\/j.ijrobp.2024.09.051_bib0020","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0167-8140(86)80061-5","article-title":"Alpha\/beta value and the importance of size of dose per fraction for late complications in the supraglottic larynx","volume":"7","author":"Maciejewski","year":"1986","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2024.09.051_bib0021","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/j.ijrobp.2008.10.013","article-title":"Fractionated stereotactic radiotherapy as reirradiation for locally recurrent head and neck cancer","volume":"74","author":"Roh","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.09.051_bib0022","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.ijrobp.2008.09.022","article-title":"Stereotactic body radiation therapy for primary, recurrent, and metastatic tumors in the head-and-neck region","volume":"74","author":"Siddiqui","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.09.051_bib0023","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/COC.0b013e3181aacba5","article-title":"Fractionated stereotactic body radiation therapy in the treatment of previously-irradiated recurrent head and neck carcinoma: updated report of the University of Pittsburgh experience","volume":"33","author":"Rwigema","year":"2010","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2024.09.051_bib0024","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0167-8140(97)00162-X","article-title":"The linear-quadratic transformation of dose-volume histograms in fractionated radiotherapy","volume":"46","author":"Wheldon","year":"1998","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2024.09.051_bib0025","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.ijrobp.2016.02.049","article-title":"Risk of severe toxicity according to site of recurrence in patients treated with stereotactic body radiation therapy for recurrent head and neck cancer","volume":"95","author":"Ling","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.09.051_bib0026","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1186\/s13063-022-06841-5","article-title":"Voices: voice quality after transoral co(2) laser surgery versus single vocal cord irradiation for unilateral stage 0 and I glottic larynx cancer-a randomized phase III trial","volume":"23","author":"Reinhardt","year":"2022","journal-title":"Trials"},{"key":"10.1016\/j.ijrobp.2024.09.051_bib0027","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.semradonc.2017.04.007","article-title":"Emphasis on repair, not just avoidance of injury, facilitates prudent stereotactic ablative radiotherapy","volume":"27","author":"Kim","year":"2017","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2024.09.051_bib0028","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00405-013-2608-8","article-title":"Radiotherapy for T1a glottic cancer: the influence of smoking cessation and fractionation schedule of radiotherapy","volume":"271","author":"Al-Mamgani","year":"2014","journal-title":"Eur Arch Oto-Rhino-Laryngol"},{"key":"10.1016\/j.ijrobp.2024.09.051_bib0029","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.anl.2022.08.007","article-title":"COVID-19 Omicron variant-induced laryngitis","volume":"50","author":"Kimura","year":"2023","journal-title":"Auris Nasus Larynx"},{"key":"10.1016\/j.ijrobp.2024.09.051_bib0030","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s15010-022-01808-9","article-title":"Endoscopic findings of laryngitis caused by SARS-CoV-2\/Omicron variant infection","volume":"51","author":"Nishiyama","year":"2023","journal-title":"Infection"},{"key":"10.1016\/j.ijrobp.2024.09.051_bib0031","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ijrobp.2015.06.016","article-title":"Single vocal cord irradiation: image guided intensity modulated hypofractionated radiation therapy for T1a glottic cancer: early clinical results","volume":"93","author":"Al-Mamgani","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.09.051_bib0032","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1002\/ohn.263","article-title":"Longitudinal patient-reported voice quality in early-stage glottic cancer","volume":"168","author":"Dorr","year":"2023","journal-title":"Otolaryngol Head neck surg"},{"key":"10.1016\/j.ijrobp.2024.09.051_bib0033","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ijrobp.2007.09.045","article-title":"Use of external beam radiotherapy is associated with reduced incidence of second primary head and neck cancer: a seer database analysis","volume":"71","author":"Rusthoven","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.09.051_bib0034","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.radonc.2009.08.005","article-title":"Reduced risk of head and neck second primary tumors after radiotherapy","volume":"93","author":"Rennemo","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2024.09.051_bib0035","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.ijrobp.2008.01.012","article-title":"Beam path toxicities to non-target structures during intensity-modulated radiation therapy for head and neck cancer","volume":"72","author":"Rosenthal","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.09.051_bib0036","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.oraloncology.2018.11.015","article-title":"Intensity modulated proton therapy (IMPT) \u2013 the future of IMRT for head and neck cancer","volume":"88","author":"Moreno","year":"2019","journal-title":"Oral Oncol"},{"key":"10.1016\/j.ijrobp.2024.09.051_bib0037","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s12874-020-01012-z","article-title":"Practicalities in running early-phase trials using the time-to-event continual reassessment method (TITE-CRM) for interventions with long toxicity periods using two radiotherapy oncology trials as examples","volume":"20","author":"van Werkhoven","year":"2020","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.ijrobp.2024.09.051_bib0038","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1111\/j.0006-341X.2000.01177.x","article-title":"Sequential designs for phase I clinical trials with late-onset toxicities","volume":"56","author":"Cheung","year":"2000","journal-title":"Biometrics"},{"key":"10.1016\/j.ijrobp.2024.09.051_bib0039","doi-asserted-by":"crossref","first-page":"902","DOI":"10.3109\/0284186X.2012.728292","article-title":"The impact of fractionation in SBRT: analysis with the linear quadratic model and the universal survival curve model","volume":"52","author":"Wennberg","year":"2013","journal-title":"Acta Oncol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301624034527?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301624034527?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T19:34:52Z","timestamp":1741635292000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301624034527"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S0360301624034527"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2024.09.051","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stereotactic Radiation Therapy in 3 Fractions for T1 Glottic Cancer","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2024.09.051","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}